196 related articles for article (PubMed ID: 6388310)
1. CEA and NCA in benign and malignant breast tumors.
Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
Wittekind C; von Kleist S; Sandritter W
Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
[TBL] [Abstract][Full Text] [Related]
4. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients.
Ura Y; Ochi Y; Hamazu M; Ishida M; Nakajima K; Watanabe T
Cancer Lett; 1985 Jan; 25(3):283-95. PubMed ID: 2578868
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
8. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
[TBL] [Abstract][Full Text] [Related]
12. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
13. Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.
Robbins PF; Eggensperger D; Qi CF; Schlom J
Int J Cancer; 1993 Apr; 53(6):892-7. PubMed ID: 8386136
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic analysis of colorectal carcinomas with monoclonal antibodies 47D10 and anti-carcinoembryonic antigen.
Keep JC; Benson AB; Sullivan MD; Carney WP; Rosen ST; Radosevich JA
Tumour Biol; 1989; 10(3):153-63. PubMed ID: 2762739
[TBL] [Abstract][Full Text] [Related]
15. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid.
Kakudo K; Takami H; Katayama S; Matsuura N; Kamoshida S; Miyauchi A; Watanabe K
Acta Pathol Jpn; 1990 Apr; 40(4):261-6. PubMed ID: 2371832
[TBL] [Abstract][Full Text] [Related]
18. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
19. Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2).
Börmer OP
Clin Chem; 1991 Oct; 37(10 Pt 1):1736-9. PubMed ID: 1914175
[TBL] [Abstract][Full Text] [Related]
20. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
